This war "epidemic", I am!
Release time:
2020-07-15
Donations Donations Guaranteed Supply
Spike Help New Crown Epidemic Prevention and Control
On February 11, Spike Pharmaceutical Company, through the Red Cross Society of Jinhua City, directed to Jinhua City Central Hospital donated 200000 yuan in cash and 100 barrels of 75% unilateral ethanol disinfectant for the hospital's new crown pneumonia epidemic prevention and control needs. This is the fourth special donation made by Jianfeng Group and its subsidiaries since the outbreak of the epidemic.
The new coronary pneumonia epidemic was first discovered in Wuhan, showing a fast spread, wide range of impact, extremely harmful characteristics, as the outbreak coincides with the Spring Festival, the dense flow of people to create conditions for the spread of the virus, but also to the epidemic prevention and control work around the pressure. Medical institutions in most provinces across the country are in urgent need of protective materials, and there is also a market shortage of alcohol, masks and other ordinary daily health protective products.
On January 25, the first day of the Lunar New Year, entrusted by the group company, daye peak cement company donated 1 million yuan to daye municipal government to purchase medical materials for the prevention and control of the new coronary pneumonia epidemic. On February 1, Yunnan Jianfeng Cement Company donated a batch of protective masks to the government of Liushun Town, Simao District, Pu 'er City, and went to the local prevention and control card point to comfort the staff. February 2, shanghai Beika Pharmaceutical Technology Co., Ltd., a subsidiary of Jianfeng, donated cash 300000 yuan and 200 sets of protective clothing, 100 pairs of canvas gloves and 2000 medical masks to the Red Cross Society of Dongzhi County, Anhui Province. To the peak pharmaceutical to Jinhua Central Hospital targeted donation, the peak group and its subsidiaries have donated cash and materials worth more than 1.5 million yuan for the prevention and control of the epidemic.
In addition to targeted donations to medical institutions, the peak man has also done a lot of work for the daily prevention and control of the epidemic in Jinhua City. At the beginning of the outbreak, the majority of employees of Peak Pharmaceuticals and its subordinate Jinhua Pharmaceutical Company and Peak Pharmacy gave up rest and organized the purchase of masks, alcohol, thermal guns, disinfectants, protective clothing and other epidemic prevention supplies through various channels. According to incomplete statistics, since the outbreak of the epidemic, the medical material circulation enterprises under the peak have organized the deployment of more than 64000 masks, more than 300 warm guns, more than 200,000 pairs of disposable medical gloves, and various epidemic prevention supplies such as disinfection nights and protective clothing. In addition to supplying citizens, they have also assisted the government in storing epidemic prevention drugs and cooperated with Jinhua Economic and Information Bureau in requisitioning epidemic prevention supplies.
Group Chairman Jiang Xiaomeng said that the epidemic is ruthless, the peak has love, the current new crown epidemic needs the people of the whole country to work together to overcome the difficulties, the peak as a well-known listed company, has the responsibility to contribute to the prevention and control of the epidemic. "I believe that if we unite as one and cheer together, we will surely win this battle without gunpowder smoke!"
Implement the responsibility and take more measures
to do a good job in internal epidemic prevention and control
The epidemic prevention and control work within Jianfeng Group started as early as around New Year's Day. Since the online media disclosed the news of the occurrence of viral pneumonia infectious diseases in Wuhan, it has attracted great attention from the leaders of the group, and early reminded the Daye Jianfeng Cement Company adjacent to Wuhan to pay attention to relevant information and implement preventive measures in a timely manner. Before the relevant departments have officially released the epidemic information, Daye Peak has formulated the epidemic prevention and control plan according to the 2003 SARS epidemic prevention standard, strengthened internal sanitation, disinfection and other work, and put forward epidemic prevention requirements for all employees, especially the sales staff in Wuhan area and Wuhan employees. With the development of the epidemic, prevention and control measures have been adjusted and implemented accordingly to ensure the stability of the production organization and the state of mind of employees.
Due to the intensive movement of people during the Spring Festival, the Group has been paying great attention to the development of the epidemic and making predictions accordingly. After learning the information that the epidemic has spread outside Hubei Province, on January 21, the company successively issued the "Notice on Prevention of Novel Coronavirus Pneumonia" and "Supplementary Notice on Prevention of Novel Coronavirus Pneumonia" to make arrangements for epidemic prevention during the Spring Festival and remind employees of the problems that should be paid attention to during the holidays. The Group set up a leading group for the prevention and control of the new coronavirus epidemic, headed by Chairman Jiang Xiaomeng, and the leading groups for the prevention and control of the epidemic and the working groups for personnel control, isolation and treatment, environmental disinfection and material security of the subordinate enterprises were also set up to divide the work and implement the responsibilities. Starting from January 28, every day, the company's employees' trends during the Spring Festival, contacts and other relevant information, timely summary, investigation of possible hidden dangers of the epidemic, to ensure that if there is a situation can be found in time, effective disposal, to achieve "early discovery, early reporting, early isolation, early treatment".
According to the development of the epidemic situation, on the third day of the new year on January 27, the group company held an emergency meeting on the prevention and control of the epidemic situation. After the meeting, the "Notice of Jianfeng Group on Preventing Novel Coronavirus Pneumonia (No. 2)" was issued to make further requirements for the adjustment and implementation of epidemic prevention and control measures, and to adjust the holiday time in time according to relevant government regulations. On February 3, the Group held a special conference call with the participation of the heads of the subordinate enterprises to put forward requirements for the prevention and control of the epidemic.
During the Spring Festival holiday, epidemic prevention and control staff at all levels kept in close contact with the epidemic prevention and control leading group of the group company, communicated the requirements of the group's epidemic prevention and control work in a timely manner through the "group epidemic prevention and control" WeChat group, exchanged epidemic information, prevention and control work of various enterprises and personnel trends, and disseminated epidemic prevention and control knowledge such as the "novel coronavirus infection pneumonia prevention manual" and "and" and "in the unit canteen; each enterprise also conveys the company's relevant requirements and health and epidemic prevention knowledge to every employee through QQ, WeChat, mobile phone short messages, publicity boards and other forms according to their actual conditions. Each enterprise has formulated a scientific and orderly prevention and control plan and emergency plan for the new coronary pneumonia epidemic situation for the resumption of work and production, from the control of people flow and traffic flow to the distribution of epidemic prevention materials, from disinfection of public areas to time-sharing of meals for employees, from the investigation of the hidden dangers of the epidemic to the dynamic management of the health status of employees, detailed and specific provisions have been made to lay a good foundation for the resumption of work and production.
On January 31, Chairman Jiang Xiaomeng, General Manager Yu Jianhong, and Deputy General Manager Xiang Chongping of the Group Company went to the Peak Pharmacy to express their condolences to the employees who worked overtime during the Spring Festival and fought on the front line of the epidemic, checked and implemented the epidemic prevention and control work, and deployed the next step in the epidemic prevention and control work. After the resumption of work on February 10, the leaders of the group company also went deep into the grass-roots enterprises to inspect and guide the epidemic prevention and control work, understand the resumption of work, condolences to front-line employees, further implement the epidemic prevention and control work, to ensure that the enterprise can operate safely.
Work together to prevent death
Enterprises have resumed work in an orderly manner
With the end of the Spring Festival holiday approaching, how to do a good job in the prevention and control of the epidemic at the same time to do a good job of enterprises to resume work and production, is an urgent need for enterprises to solve the problem. Among the enterprises under the Sharp Peak Group, whether in Jinhua or in other provinces, they have received support and help from the government management department where the enterprise is located, and the relevant person in charge has visited the enterprise site many times to investigate and understand the enterprise's epidemic prevention and control and preparations for the resumption of work.
The Jindong District Government also made a special case to allow the Jianfeng International Trade Warehouse to unload the wingers at the station, thus reducing the loss of goods stranded. On January 30, members of Guizhou Huangping peak management team bid farewell to their families and went to work; on February 1, a group of management backbones of Yunnan peak also returned to the enterprise; on February 9, the "peak retrograde"-Daye peak Jinhua management backbones set out to return to Hubei, further comprehensive arrangements for the implementation of epidemic prevention and control and resumption of work.
Doing a good job of epidemic prevention and control is a prerequisite for the resumption of work. As the main body of the resumption of work, as early as during the Spring Festival holiday, after the state, province and city made relevant regulations and requirements for the resumption of work, the group company began to make relevant preparations, according to the actual situation of each enterprise, to find out the whereabouts and contacts of employees during the holiday, and to investigate the hidden dangers of the epidemic. Issued "Notice on Resuming Work after the Spring Festival in 2020" and "Matters needing attention for resuming work after the Spring Festival in 2020". Through various channels to every employee; organize employees to seriously study epidemic prevention knowledge, epidemic prevention and control during the matters needing attention and other resumption of training materials, for the resumption of work after the production, epidemic prevention and control of both hands to do a good job in the early preparation. On February 7, the Group held a special conference call to arrange for the resumption of work to make arrangements for production and epidemic prevention after the resumption of work. In accordance with the territorial government's requirements for resumption of work, each enterprise prepares relevant information and applies for resumption of work. Due to the full preparation, to do the measures in place, personnel in place, responsibility in place, the resumption of work required epidemic prevention supplies in place, Jianfeng Group headquarters by the Wucheng District Party Committee and government included in the first batch of 47 resumption of work enterprises list, peak pharmaceutical industry is also listed as the first approval of the development zone enterprises.
At present, the headquarters of the group company and Jianfeng Pharmaceutical Co., Ltd. resumed work on February 10, Jianfeng Health Technology Co., Ltd. resumed work on February 11, and Cable Co., Ltd. resumed work on February 13. The application for resumption of work by Jianfeng International Trade Company and Jinhua Pharmaceutical Company has been approved. Peak Pharmacy has been working normally during the Spring Festival because it undertakes the task of purchasing and selling epidemic prevention materials. Among foreign enterprises, Hubei Province requires that construction is not allowed before February 20, daye peak directly affected, Guizhou Huangping peak, Anhui Zhongwang Pharmaceutical's application for resumption of work has been approved by the management department, Yunnan peak production is normal, Tianjin enterprises are going through the approval procedures for resumption of work.
From the resumption of work at the Group's headquarters on February 10, the Group's leaders went separately to various subsidiaries in Jinhua to carefully understand the implementation of epidemic prevention and control measures and preparations for the resumption of work. At present, while doing a good job in the management requirements for Jinhua enterprises to resume work, enterprises have further strengthened epidemic safety warnings, posting epidemic risk notification cards in office areas and key areas of the factory to ensure that each employee can clearly understand relevant prevention and control measures and improve their epidemic protection ability. Sign an epidemic prevention commitment with subordinate enterprises and each employee to strengthen the prevention and control awareness of all employees. Every day, the body temperature of all employees to and from work, the work area personnel into the management and information registration, employee health dynamic information daily, regular distribution of protective equipment, public areas twice a day of comprehensive disinfection ...... become the "compulsory course" of the enterprise management department ". Due to the requirements of epidemic prevention and control, the current enterprises are only part of the resumption of work, there are varying degrees of staff to the post rate is insufficient, can not meet the normal production needs and other issues, each enterprise according to their own situation, to carry out comprehensive equipment maintenance, technical transformation, and constantly check the leak to fill the gap, for the upcoming full resumption of work to make full preparations.
Since the outbreak of the new coronary pneumonia epidemic, the sharp peak group attaches great importance to, from the group headquarters to the subordinate enterprises, are actively organizing the implementation of the epidemic prevention and control work, multi-measures, effectively protect the life safety and health of all the company's cadres and employees. So far, no cases of new crown pneumonia have been found in the whole group, and the state of mind of employees is stable. (Fu Yiwu Ni Yingzhen Fonz)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31